Alternative splice variants of the human PD-1 gene

Cellular Immunology

Volumn 235, Issue 2, 2005, Pages 109-116

  Nielsen, Christian ^a   Ohm Laursen, Line ^a   Barington, Torben ^a   Husby, Steffen ^a   Lillevang, Søren T ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Alternative splicing; Co stimulation; PD 1; PMBCs; Soluble

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; PROGRAMMED DEATH 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CODON; CONTROLLED STUDY; EXON; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA SPLICING;

ALTERNATIVE SPLICING; ANTIGENS, CD; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; EXONS; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SOLUBILITY;

EID: 27744560614     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.07.007     Document Type: Article

References (25)

1. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat. Rev. Immunol. 2 2002 116 126
2. G.J. Freeman, A.J. Long, Y. Iwa, K. Bourque, T. Chernova, H. Nishimura, L.J. Fitz, N. Malenkovich, T. Okazaki, M.C. Byrne, H.F. Horton, L. Fouser, L. Carter, V. Ling, M.R. Bowman, B.M. Carreno, M. Collins, C.R. Wood, and T. Honjo Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J. Exp. Med. 192 2000 1027 1034
3. H. Dong, G. Zhu, K. Tamada, and L. Chen B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat. Med. 5 1999 1365 1369
4. Y. Latchman, C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, E.A. Greenfield, K. Bourque, V.A. Boussiotis, L.L. Carter, B.M. Carreno, N. Malenkovich, H. Nishimura, T. Okazaki, T. Honjo, A.H. Sharpe, and G.J. Freeman PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat. Immunol. 2 2001 261 268
5. S.Y. Tseng, M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, S.I. Pai, A. Shalabi, T. Shin, D.M. Pardoll, and H. Tsuchiya B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells J. Exp. Med. 193 2001 839 846
6. T. Okazaki, A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine Proc. Natl. Acad. Sci. USA 98 2001 13866 13871
7. H. Nishimura, M. Nose, H. Hiai, N. Minato, and T. Honjo Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 11 1999 141 151
8. H. Nishimura, T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 2001 319 322
9. E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 Immunity 3 1995 541 547
10. P. Waterhouse, J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 Science 270 1995 985 988
11. L. Prokunina, C. Castillejo-Lopez, F. Oberg, I. Gunnarsson, L. Berg, V. Magnusson, A.J. Brookes, D. Tentler, H. Kristjansdottir, G. Grondal, A.I. Bolstad, E. Svenungsson, I. Lundberg, G. Sturfelt, A. Jonssen, L. Truedsson, G. Lima, J. Alcocer-Varela, R. Jonsson, U.B. Gyllensten, J.B. Harley, D. Alarcon-Segovia, K. Steinsson, and M.E. Alarcon-Riquelme A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in human Nat. Genet. 32 2002 666 669
12. C. Nielsen, D. Hansen, S. Husby, B.B. Jacobsen, and S.T. Lillevang Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes Tissue Antigens 62 2003 492 497
13. S.C. Lin, J.H. Yen, J.J. Tsai, W.C. Tsai, T.T. Ou, H.W. Liu, and C.J. Chen Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus Arthritis Rheum. 50 2004 770 775
14. C. Nielsen, H. Laustrup, A. Voss, P. Junker, S. Husby, and S.T. Lillevang A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients Lupus 13 2004 510 516
15. G. Magistrelli, P. Jeannin, N. Herbault, A. Benoit De Coignac, J.F. Gauchat, J.Y. Bonnefoy, and Y. Delneste A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells Eur. J. Immunol. 29 1999 3596 3602
16. M.K. Oaks, and K.M. Hallett Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease J. Immunol. 164 2000 5015 5018
17. M.K. Oaks, K.M. Hallett, R.T. Penwell, E.C. Stauber, S.J. Warren, and A.J. Tector A native soluble form of CTLA-4 Cell. Immunol. 201 2000 144 153
18. M.F. Liu, C.R. Wang, P.C. Chen, and L.L. Fung Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus Scand. J. Immunol. 57 2003 568 572
19. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. Ionescu-Tirgoviste, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd, and S.C. Gough Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506 511
20. S.A. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 2000 169 193
21. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J. Mol. Endocrinol. 29 2002 23 39
22. L.R. Finger, J. Pu, R. Wasserman, R. Vibhakar, E. Louie, R.R. Hardy, P.D. Burrows, and L.G. Billips The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors Gene 197 1997 177 187
23. X. Zhang, J.C. Schwartz, X. Guo, S. Bhatia, E. Cao, L. Chen, Z.Y. Zhang, M.A. Edidin, S.G. Nathenson, and S.C. Almo Structural and functional analysis of the costimulatory receptor programmed death-1 Immunity 3 2004 337 347
24. T. Schell, T. Kocher, M. Wilm, B. Seraphin, A.E. Kulozik, and M.W. Hentze Complexes between the nonsense-mediated mRNA decay pathway factor human upf1 (up-frameshift protein 1) and essential nonsense-mediated mRNA decay factors in HeLa cells Biochem. J. 373 2003 775 783
25. B.P. Lewis, R.E. Green, and S.E. Brenner Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans Proc. Natl. Acad. Sci. USA 100 2003 189 192